Philadelphia – Based on previous studies, a group of researchers of the Institute of Cell Biology and Neurobiology of the National Research Council (CNR-IBCN) have identified a potential new therapeutic approach for the treatment of cancer, through the reactivation of the p53 protein, a tumor suppressor considered one of the most important factors to control the development and progression of the disease. The findings were published in the journal Cancer Research. The work involved the cooperation of the University of Perugia, the Catholic University of Rome, Istituto Regina Elena, the European Institute for Brain Research (EBRI) -Rita Levi Montalcini and the University of Leuven in Belgium. (9Colonne)
